Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Nursing and Health Professions

• Myositis 100%
• Disease Activity 40%
• Comorbidity 40%
• Prednisolone 40%
• Rituximab 40%
• Equivalent Dose 40%
• Remission 20%
• Logistic Regression Analysis 20%
• Disease Modifying Antirheumatic Drug 20%

Medicine and Dentistry

• Myositis 100%
• COVID-19 100%
• Disease Activity 20%
• Rituximab 20%
• Equivalent Dose 20%
• Prednisolone 20%
• Risk Stratification 10%
• Logistic Regression Analysis 10%
• Disease Modifying Antirheumatic Drug 10%